DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.

Author(s): Lo YL, Lum SY, Fook-Chong S, Siow HC

Affiliation(s): Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Outram Road, Singapore, Singapore. gnrlyl@sgh.com.sg

Publication date & source: 2010-04, J Headache Pain., 11(2):175-8. Epub 2010 Feb 9.

Publication type: Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017